Biogen Idec Advises Use Of Avonex Powder Formulation To Prevent Shortage
This article was originally published in The Pink Sheet Daily
Executive Summary
An April 29 Dear Health Care Professional letter says Biogen Idec “may experience” a shortage of the liquid formulation of the MS therapy due to manufacturing impurity issues.
You may also be interested in...
Avonex Manufacturing Update: New Liquid Fill-Finish Process Validated
Biogen Idec has completed validation of a new fill-finish process for the liquid formulation of Avonex.
Avonex Manufacturing Update: New Liquid Fill-Finish Process Validated
Biogen Idec has completed validation of a new fill-finish process for the liquid formulation of Avonex.
Biogen Addressing Avonex Liquid Formulation Manufacturing Problems
Pre-filled syringe process is experiencing a "technical issue" on the fill-finish side. Biogen has the option to ramp up production of Avonex' original lyophilized powder formulation to make up for shortages on the liquid side.